StockWatch
·
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Quarterly ResultJul 29, 2026, 04:17 PM

Axogen Repays $69.7M Debt with $133.3M Equity Offering

AI Summary

Axogen, Inc. reported its Q2 2026 financial results, showing revenue growth but a shift to net loss. The company successfully repaid its $69.7 million Credit Facility debt in January 2026, funded by a $133.3 million net proceeds equity offering. For the second quarter, revenues increased to $69.7 million, but the company posted a net loss of $1.5 million, compared to a net income in the prior year. The six-month period saw a net loss of $21.1 million, significantly impacted by a $16.8 million loss on debt extinguishment.

Key Highlights

  • Repaid $69.7 million Credit Facility debt using equity offering proceeds.
  • Raised $133.3 million net from public offering of 4.6 million common shares.
  • Q2 2026 revenue grew to $69.7 million from $56.7 million year-over-year.
  • Q2 2026 net loss was $1.5 million, compared to $0.6 million net income year-over-year.
  • Six-month 2026 net loss increased to $21.1 million from $3.3 million year-over-year.
  • Net cash provided by operating activities was $8.8 million for six months 2026.
  • Cash and cash equivalents rose to $94.6 million as of June 30, 2026.